Ronjon Nag OBE

Inventor | Entrepreneur | Investor | @stanford Adjunct Professor Genetics | Founder & Managing Partner @R42group

[Ronjon Nag OBE @RonjonNag]

@AgemicaCom It's great we actually post the development plan so we can get feedback from the community. Look forward to more posts on how Agemica is going to fulfil its mission. The vaccine plan next ....

[Ronjon Nag OBE @RonjonNag]

Our founders are practitioners not just exec suite

[Agemica @AgemicaCom]

Longevity escape velocity doesn't require solving immortality in one leap.

If you extend healthy lifespan by 10 to 20 years, and the treatments developed during that window extend it again. Repeat enough times, and progress starts outrunning time itself.

Our team is working every day to reach escape velocity for humanity.

[Ronjon Nag OBE @RonjonNag]

@BoWang87 Better to have less medicines that do more things - that’s what we are doing at Agemica.

[Ronjon Nag OBE @RonjonNag]

Stanford AI Longevity Lab certificate course starts tomorrow Tuesday Sept 29th 6-8pm either in person at Stanford or online. No pre reqs. Anyone can join. https://t.co/1O4jA1US56

[Ronjon Nag OBE @RonjonNag]

Thinking big….

[Agemica @AgemicaCom]

"Imagine a world where people don't age."

Agemica founder @RonjonNag targets a future where a shot every 5–10 years keeps people healthy, and disrupts traditional biotech.

How do we get to this stage?

(01) Start with cancer.

Agemica’s mission begins with a more specific challenge: finding treatments that kill cancer cells while sparing healthy tissue.

That gives the research a starting point.
> Which candidates work?
> At what concentrations?
> How selectively?
> Which results hold up when tested again?

(02) Find better combinations of existing medicines.

Agemica uses frontier AI to identify combinations of known drugs that could work together against disease.

In computational testing, the platform rediscovered established standards of care across 17 cancers. That provides a benchmark for investigating the less obvious combinations its models suggest.

(03) Develop vaccines with protection that lasts.

Alongside therapies, Agemica is developing peptide and mRNA vaccine designs intended to train the immune system against disease-associated targets.

This is the longer-term ambition behind Ronjon’s vision: interventions that help the body maintain protection over years, with periodic doses to sustain it.
Establishing how well that protection works and how long it lasts is part of the research ahead.

more time to work, travel, raise a family, and remain independent - with health that lets us use those years.

$AGE

[Ronjon Nag OBE @RonjonNag]

@AgemicaCom the Agemica waiting list is now available at https://t.co/EI0rUvCd9f !!

[Ronjon Nag OBE @RonjonNag]

We now have an Agemica token !

[Street Foundation @StreetFDN]

Street is excited to support their token $AGE. (0x5733507868f46d96907132f98431dceef67c69cc)

You hold tokens to get points on Agemicas waiting list, the more points you have the higher your priority access for Agemica products is.

Additionally Street Global Foundation holds 10% equity of Agemica through a SAFE note.

Agemica holds 75% of the $AGE token supply, subject to vesting. Street holds transparency as one of our key values, thus any potential future token sale of this team allocation Agemica will do will be documented publicly with the relevant docs of where this money flows to and what it's being used for.

The token is only eligible for non US citizens.

For all questions and IR please join our Discord.
https://t.co/457hu0OnhN

[Ronjon Nag OBE @RonjonNag]

@StreetFDN @AgemicaCom Fantastic to get a disruptive approach to get a community to help solve the main diseases that plague humanity.

[Ronjon Nag OBE @RonjonNag]

Thinking big, long and hard - accomplish great things. You have to ask the big question first and then set about to accomplish it. The aging vaccine. @Snyder_Lab_SU @R42group @AgemicaCom @sophieliu @JayRajadas

[Agemica @AgemicaCom]

Introducing Agemica.

On our mission to solve aging.

[Agemica @AgemicaCom]

Introducing Agemica.

On our mission to solve aging.

[Ronjon Nag OBE @RonjonNag]

@a16z Similar model to R42 Institute where we are taking high schoolers who with AI they can make new medicines

[Ronjon Nag OBE @RonjonNag]

Looking forward to going on MCG at 11am PT where we will talk about Agemica’s aging vaccine.

[MCG @MCGlive]

🔴 LIVE: Bears Are Cooked | $600M BTC Shorts Liquidated | Market Update + Interviews https://t.co/y8aS14LrwJ

[MCG @MCGlive]

🔴 LIVE: Bears Are Cooked | $600M BTC Shorts Liquidated | Market Update + Interviews https://t.co/y8aS14LrwJ

[Ronjon Nag OBE @RonjonNag]

Really fantastic to work StreetFDN with innovative ways to grow deep science moonshots

[Street Foundation @StreetFDN]

Excited to work together with @AgemicaCom on their mission to solve aging.

[Ronjon Nag OBE @RonjonNag]

Most don't understand that solving aging is just about adding a year to the average human lifespan again and again.

[Ronjon Nag OBE @RonjonNag]

I run 20 to 30 miles a week.

The specific number matters less than never stopping.

The biggest risk at 60 is injury. Take a week off every few weeks. I run at intensities I can sustain rather than intensities that impress me. Compound over years.

[Ronjon Nag OBE @RonjonNag]

I shipped my first AI product in 1984.

A laptop that could recognize about a hundred spoken commands from one specific speaker.

It was mostly a novelty. It proved the technology had crossed a useful threshold. I've been shipping AI products since.

[Ronjon Nag OBE @RonjonNag]

Most longevity supplements show tiny effects at best because they're single-agent interventions targeting multi-target problems. Metformin, NAD precursors, rapamycin analogs. Each hits one node in a network with fifteen other nodes doing similar work.

[Ronjon Nag OBE @RonjonNag]

The gap between preclinical and clinical translation in oncology has narrowed slightly in the last five years. The gap in aging biology remains enormous. Most interventions that look transformative in mice have modest or no effect in humans.

[Ronjon Nag OBE @RonjonNag]

The most underrated moment in biology in the last decade was AlphaFold

Protein structure wasn't the endpoint. The importance was proving that biological problems previously considered intractable were actually tractable given the right data and models.